My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$CSX {{ '2015-07-15T11:58:15+0000' | timeago}} • Announcement

$CSX 2Q15 PR: Revenue declined 6% or $180MM to $3,064MM compared to $3,244MM in 2Q14, as pricing gains were more than offset by impact of lower fuel recovery, a 1% volume decline & changing business mix. Net earnings increased 5% or $24MM to $553MM compared to $529MM in 2Q14. Operating income increased $20MM to $1,017MM compared to $997MM in 2Q14.

User Mark Collas {{ '2016-10-25T20:12:01+0000' | timeago}}

Waiting with fingers crossed for $AAPL’s fourth quarter earnings.

User RC xNair {{ '2016-10-25T17:04:47+0000' | timeago}}

Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."

User Carlton Davis {{ '2016-10-24T19:31:20+0000' | timeago}}

$COL agreed to buy $BEAV for $6.4 billion in cash and stock. Also Rockwell Collins reported higher 4Q16 earnings on growth in Government Systems and higher revenue in Information Management Services.

User Charles Elliston {{ '2016-10-24T19:15:21+0000' | timeago}}

Wow! What a buzz the $T-$TWX deal is making! Almost everyone from politicians to competitors have come out against this deal. Even Wall Street doesn’t seem to be too thrilled. Both stocks were down today.

User Vishnu Beri {{ '2016-10-24T17:33:28+0000' | timeago}}

Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.

$AKAM {{ '2016-10-25T21:11:14+0000' | timeago}} • Webcast

Sales in $AKAM's international markets represented 31% of total revenue in 3Q16, consistent with 2Q16 and up 4 points from 3Q15. International revenue was $180MM in 3Q16, up 20% YoverY or up 17% in constant currency. ForEx fluctuations had a positive impact on revenue, $3MM on a YoverY basis and no impact on revenue on a sequential basis.

$JNPR {{ '2016-10-25T21:10:48+0000' | timeago}} • Announcement

Network services provider $JNPR reported a drop in 3Q16 earnings due to higher costs and expenses despite a 3% increase in revenue. Net income fell to $172.4MM or $0.45 per share from $197.7MM or $0.51 per share last year. Revenue grew to $1.29Bil from $1.25Bil. Non-GAAP EPS rose to $0.58 from $0.57.

$VRTX {{ '2016-10-25T21:09:37+0000' | timeago}} • Webcast

For 2016, $VRTX reiterated the lowered revenue outlook for cystic fibrosis treating drug Orkambi, hurt by U.S. treatment trends and ongoing slower-than-expected launch in Germany. The company will not be able to recognize the revenue for patients in France until it achieves a formal reimbursement agreement.

$VRTX {{ '2016-10-25T21:09:33+0000' | timeago}} • Webcast

$VRTX said it continues to expect total 2016 product revenues for ORKAMBI of $950-$990MM. ORKAMBI treats Cystic fibrosis, which is a genetic disorder that affects mostly the lungs. The company also expects total 2016 product revenues for cystic fibrosis drug KALYDECO of $685-$705MM.

$AAPL {{ '2016-10-25T21:08:35+0000' | timeago}} • Announcement

In 4Q16, $AAPL posted iPhone revenues of $28.1Bil, down from $32.2Bil in 4Q15. Revenues from iPad totaled  $4.2Bil and Mac revenues totaled $5.7Bil. Revenues from Services totaled $6.3Bil and revenues from Other Products totaled $2.3Bil.